Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma

Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma

Tumor resection represents the only curative treatment option for patients with biliary tract cancers (BTCs), including intrahepatic cholangiocarcinoma (CCA), perihilar and extrahepatic CCA and gallbladder cancer. However, many patients develop early tumor recurrence and are unlikely to benefit from...

Full description

Bibliographic Details
Main Authors: Christoph Roderburg, Sven H. Loosen, Jan Bednarsch, Patrick H. Alizai, Anjali A. Roeth, Sophia M. Schmitz, Mihael Vucur, Mark Luedde, Pia Paffenholz, Frank Tacke, Christian Trautwein, Tom F. Ulmer, Ulf Peter Neumann, Tom Luedde
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
biliary tract cancer
cholangiocarcinoma
PD-L1
PD-1
biomarker
Online Access:https://www.mdpi.com/1422-0067/22/12/6569

Internet

https://www.mdpi.com/1422-0067/22/12/6569

Similar Items